Precigen (PGEN) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Precigen (PGEN) over the last 12 years, with Q3 2025 value amounting to -$1.06.
- Precigen's EPS (Weighted Average and Diluted) fell 107777.78% to -$1.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.39, marking a year-over-year decrease of 15272.73%. This contributed to the annual value of -$0.47 for FY2024, which is 2051.28% down from last year.
- Per Precigen's latest filing, its EPS (Weighted Average and Diluted) stood at -$1.06 for Q3 2025, which was down 107777.78% from -$0.09 recorded in Q2 2025.
- Precigen's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.44 during Q3 2022, with a 5-year trough of -$1.06 in Q3 2025.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.11 (2022), whereas its average is -$0.14.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 39333.33% in 2022, then plummeted by 107777.78% in 2025.
- Precigen's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.13 in 2021, then rose by 15.38% to -$0.11 in 2022, then dropped by 18.18% to -$0.13 in 2023, then surged by 43.32% to -$0.07 in 2024, then plummeted by 1338.59% to -$1.06 in 2025.
- Its last three reported values are -$1.06 in Q3 2025, -$0.09 for Q2 2025, and -$0.18 during Q1 2025.